Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Opinion in Immunology|March 13, 2022
Chasing neoantigens; invite naïve T cells to the partyRavi Chand Bollineni, Trung T Tran, Fridtjof Lund-Johansen, et al.Journal of Proteome Research|May 17, 2017
Identification of Alternative Splice Variants Using Unique Tryptic Peptide Sequences for Database SearchesTrung T Tran, Ravi C Bollineni, Margarita Strozynski, et al.Journal of Agricultural and Food Chemistry|December 6, 2023
Evaluation of Functional Spray Coatings for Mitigating the Uptake of Volatile Phenols by Pinot Noir Wine Grapes via Blocking, Absorption, and/or AdsorptionTrung T Tran, Jooyeoun Jung, Lindsay Garcia, et al.Journal of Food Science|December 19, 2022
Impact of functional spray coatings on smoke volatile phenol compounds and Pinot noir grape growthTrung T Tran, Jooyeoun Jung, Lindsay Garcia, et al.BMC Medicine|October 5, 2022
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort studyIngrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, et al.Cell Reports|January 19, 2023
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variantsSaskia Meyer, Isaac Blaas, Ravi Chand Bollineni, et al.RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.Blood|March 2, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myelomaKarolos Douvlataniotis, Aleksei Titov, Julia Zeun, et al.British Journal of Haematology|March 7, 2022
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccinationJon Riise, Saskia Meyer, Isaac Blaas, et al.The Lancet. Rheumatology|November 23, 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort studyKristin H Bjørlykke, Hilde S Ørbo, Anne T Tveter, et al.Pageof 2